- Report
- July 2022
- 78 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Drug Pipelines
- October 2020
- 90 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Book
- September 2023
- 288 Pages
- Book
- July 2023
- 432 Pages
- Book
- August 2022
- 560 Pages
- Book
- July 2018
- 376 Pages
- Book
- July 2015
- 328 Pages
- Book
- October 2024
- 304 Pages
- Book
- April 2024
- 896 Pages
- Book
- July 2022
- 560 Pages
United States
- Book
- August 2021
- 624 Pages
- Book
- June 2021
- 432 Pages
- Book
- September 2019
- 512 Pages
- Book
- December 2015
- 1032 Pages
- Book
- October 2013
- 464 Pages
- Book
- April 2013
- 576 Pages
- Book
- April 2024
North America

The Antiparasitic Agent market is a subset of the Infectious Diseases Drugs market, which focuses on the development and sale of drugs used to treat parasitic infections. Antiparasitic Agents are used to treat a variety of parasitic infections, including malaria, schistosomiasis, and leishmaniasis. These drugs are typically administered orally, intravenously, or topically, depending on the type of infection. Antiparasitic Agents are often used in combination with other drugs to ensure the most effective treatment.
The Antiparasitic Agent market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi, Pfizer, and Novartis. Other companies, such as Johnson & Johnson, Bayer, and AstraZeneca, also offer Antiparasitic Agents. Show Less Read more